Skip to main content

Navigation group

Type at least 3 characters
2,017 articles

Articles

Clinical Trial

Published on 26 Aug 2020

Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01

in Drugs Outcomes Research and Policies

  • Jose L. Guerrero-Orriach
  • Alfredo Malo-Manso
  • Marta Ramirez-Aliaga
  • Ana Isabel Florez Vela
  • Manuel Galán-Ortega
  • Isabel Moreno-Cortes
  • Inmaculada Gonzalez-Almendros
  • Alicia Ramirez-Fernandez
  • Daniel Ariza-Villanueva
  • Juan Jose Escalona-Belmonte
Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01331
  • 5,440 views
  • 8 citations

Original Research

Published on 14 Aug 2020

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

in Drugs Outcomes Research and Policies

  • Aneta Mela
  • Łukasz A. Poniatowski
  • Bartłomiej Drop
  • Marzena Furtak-Niczyporuk
  • Janusz Jaroszyński
  • Witold Wrona
  • Anna Staniszewska
  • Jan Dąbrowski
  • Anna Czajka
  • Beata Jagielska
Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01123
  • 7,587 views
  • 21 citations